AccessibilityHelp
Elekta Ab (publ) logo

Elekta Ab (publ)(OTC) EKTAY

Market Cap$2.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2008)+199%
5 Year-41%
1 Year+15%
1 Month+14%
$5.81
+1.49%
+0.08Today
Elekta Ab (publ) last closing stock price
MetricPriceDate
Last closeUSD 5.812026-10-26
Elekta Ab (publ) stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+4.22%USD 5.572026-10-19
1 month+14.16%USD 5.092026-09-25
3 month+19.69%USD 4.852026-07-28
Year to date-0.68%USD 5.842025-12-31
1 year+15.23%USD 5.042025-10-24
3 year-1.48%USD 5.892023-10-27
5 year-40.57%USD 9.772021-10-27
Since inception+199.36%USD 1.912008-12-12

Elekta Ab (publ) Financials at a Glance

Market Cap

$2.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

SEK 16.45B

Net Income (TTM)

-SEK 363.62M

EPS (TTM)

-$0.11

P/E Ratio

-53.11

Dividend

$0.25

Beta (Volatility)

0.74 (Low)

Price

$5.81

Volume

306

Open

$5.81

Previous Close

$5.81

Daily Range

$5.81 - $5.81

52-Week Range

$4.35 - $6.93

Estimated Earnings Date

Nov 25, 2026

EKTAY News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Elekta Ab (publ)

Elekta AB (publ) is a global medical technology company focused on developing advanced clinical solutions for cancer and brain disorder treatments. With a comprehensive portfolio of innovative radiotherapy systems and treatment management software, Elekta aims to enhance patient care and improve clinical outcomes.

Products and Services
  • Elekta Unity MR-Linac for precision radiotherapy
  • Elekta Harmony linear accelerator for diverse patient needs
  • Software solutions like MOSAIQ Plaza for integrated cancer care
Growth Outlook
  • Revenue of 3.54 billion SEK in Q1 2026 shows strong demand
  • Operating income of 389 million SEK indicates operational efficiency
  • Continued investment in R&D supports future product innovations
Financial Highlights
  • Net income of 264 million SEK in Q1 2026 reflects recovery
  • Gross profit margin improved to 42.56% in Q1 2026
  • Dividend yield of 4.17% offers attractive returns
Elekta's commitment to innovation is evident in its diverse product offerings, which cater to various oncology and neurosurgery needs. The recent quarterly performance indicates a positive trend, with significant revenue growth and improved profitability metrics. The company's focus on research and development positions it well for future advancements in medical technology. With a solid dividend yield, Elekta presents an appealing opportunity for investors interested in the healthcare sector.
AI Generated • Oct 26, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

4,102

CEO

Jakob Just-Bomholt

Website

www.elekta.com

Headquarters

Stockholm, SD 113 68, SE

EKTAY Financials

Key Financial Metrics (TTM)

Gross Margin

38.62%

Operating Margin

6.35%

Net Income Margin

-2.18%

Return on Equity

-4.66%

Return on Capital

2.96%

Return on Assets

-1.36%

Earnings Yield

-1.88%

Dividend Yield

4.43%

Payout Ratio

-2.55%

Stock Overview

Market Cap

$2.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

367.10M

Volume

306

Avg. Volume

2.39K

Financials (TTM)

Gross Profit

SEK 6.36B

Operating Income

SEK 1.03B

EBITDA

SEK 1.89B

Operating Cash Flow

SEK 2.53B

Capital Expenditure

-SEK 373.63M

Free Cash Flow

SEK 2.16B

Cash & ST Invst.

SEK 2.30B

Total Debt

SEK 6.81B

Elekta Ab (publ) Performance Analysis

Elekta Ab (publ) annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20232023-04-30SEK 1,614,476,247-1.2%
20242024-04-30SEK 1,702,409,8715.4%
20252025-04-30SEK 1,706,628,4650.2%
20262026-04-30SEK 1,780,004,6264.3%
Elekta Ab (publ) sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-10-3111.6%
Q32026-01-31-0.2%
Q42026-04-3017.4%
Q12026-07-31-25.8%
Elekta Ab (publ) annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20232023-04-30SEK 0.24-30.5%
20242024-04-30SEK 0.3235.7%
20252025-04-30SEK 0.06-81.6%
20262026-04-30SEK -0.14N/A
Elekta Ab (publ) sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22025-10-31114.3%
Q32026-01-31-95.8%
Q42026-04-30-9300.0%
Q12026-07-31130.0%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2027YOY CHG

Revenue

SEK 3.54B

-2.9%

Gross Profit

SEK 1.51B

+12.3%

Gross Margin

42.56%

N/A

Market Cap

$2.10BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$511.90K

N/A

Employees

4,102

N/A

Net Income

SEK 264.42M

+147.1%

EBITDA

SEK 522.83M

+2.7%

Quarterly Fundamentals

Name
Q1 2027YOY CHG

Total Cash

SEK 2.30B

-16.7%

Total Debt

SEK 6.81B

-12.0%

Accounts Receivable

SEK 6.61B

-13.6%

Inventory

SEK 3.49B

+15.1%

Long Term Debt

SEK 4.11B

-38.0%

Short Term Debt

SEK 2.71B

+145.1%

Return on Assets

-1.36%

N/A

Return on Invested Capital

8.58%

N/A

Free Cash Flow

-SEK 24.04M

+93.3%

Operating Cash Flow

SEK 0.00

+100.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NVCRNovocure Ltd
$14.40-1.91%
SRTSSensus Healthcare, Inc.
$2.82-4.41%
ARAYAccuray Incorporated
$0.12-5.38%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$12.59-16.95%
EWZiShares - iShares Msci Brazil ETF
$34.15-19.82%
ITUBItaú Unibanco
$7.70-20.37%
XPXP
$15.71-48.36%

Questions About EKTAY

What is the current price of Elekta Ab (publ)?

Elekta Ab (publ) is trading at $5.81 per share.

What is the 52-week range for Elekta Ab (publ)?

Over the past 52 weeks, Elekta Ab (publ) has traded between $4.35 and $6.93.

How much debt does Elekta Ab (publ) have?

As of the most recent reporting period, Elekta Ab (publ) reported total debt of SEK 715.93M.

How much cash does Elekta Ab (publ) have on hand?

Elekta Ab (publ) reported SEK 241.61M in cash and cash equivalents in its most recent financial results.

What is Elekta Ab (publ)’s dividend yield?

Elekta Ab (publ) currently has a dividend yield of 4.43%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services